Abstract
<p>Figure S1: Schematic representation of the AOM-DSS experimental design. Figure S2: Dietary emulsifiers promote metabolic syndrome and low-grade intestinal inflammation in WT mice. Figure S3: Colonic histology analysis of emulsifiers promotion of colitis-associated cancer. Figure S4: Dietary emulsifiers induce alterations of the microbiota. Figure S5: Alpha diversity and summarized taxa of the fecal bacterial community following emulsifier treatment. Figure S6: Identification of bacterial members differentially expressed between experimental groups. Figure S7: Dietary emulsifiers favor a pro-inflammatory microbiota. Figure S8: Metagenome prediction analysis following CMC consumption. Figure S9: Metagenome prediction analysis following P80 consumption. Figure S10: Dietary emulsifiers alter epithelial cell proliferation and apoptosis during colitis-associated cancer development. Figure S11: Dietary emulsifier and AOM injection experiment.</p>
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
